IFNA1 and breast carcinoma: Given that PD-L1 expression is associated with downstream IFN signalling [47–49], we also validated that 15a significantly enhances PD-L1 expression in breast cancer cells at both the protein and mRNA levels (Fig. 6A, B and Fig. S3A).